Reuters logo
BRIEF-Lumosa Therapeutics gets TFDA approval for its long-acting analgesic injection named NALDEBAIN,LT1001
March 6, 2017 / 11:11 AM / 8 months ago

BRIEF-Lumosa Therapeutics gets TFDA approval for its long-acting analgesic injection named NALDEBAIN,LT1001

March 6 (Reuters) - Lumosa Therapeutics Co Ltd:

* Says it got Taiwan Food and Drug Administration (TFDA) approval for its long-acting analgesic injection named NALDEBAIN LT1001

Source text in Chinese: goo.gl/f49CB7

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below